(Q36198484)

12 August 2017

1 reference

title

Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications (English)

1 reference

12 August 2017

0 references

0 references

chronic heart failure

1 reference

1

Pål Aukrust

0 references

Jan Kristian Damås

series ordinal

4

object named as

Jan K Damås

1 reference

12 August 2017

3

Thor Ueland

1 reference

12 August 2017

2

Lars Gullestad

1 reference

12 August 2017

5

Arne Yndestad

1 reference

PubMed ID

16026115

12 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

37

1 reference

12 August 2017

74-85

1 reference

12 August 2017

2

1 reference

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

12 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Antibiotics for secondary prevention of coronary artery disease: an ACES hypothesis but we need to PROVE IT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Cyclic stretch upregulates production of interleukin-8 and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

The role of oxidative stress in the genesis of heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Pathophysiological role of cytokines in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Inflammatory mediators and the failing heart: past, present, and the foreseeable future

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

The role of tumor necrosis factor in the pathophysiology of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Elevated levels of activin A in heart failure: potential role in myocardial remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Biology of the TRANCE axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Impaired beta-adrenergic control of immune function in patients with chronic heart failure: reversal by beta1-blocker treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Effect of metoprolol on cytokine levels in chronic heart failure--a substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Effect of thalidomide in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Thalidomide in the treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Impact of HMG CoA reductase inhibition on small GTPases in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Complement activation in patients with congestive heart failure: effect of high-dose intravenous immunoglobulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Stem-cell transplantation in myocardial infarction: a status report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Pluripotent cells (stem cells) and their determination and differentiation in early vertebrate embryogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

The B7/CD28/CTLA4 T-cell activation pathway. Implications for inflammatory lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Evidence for a role of mast cells in the evolution to congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

Inhibition of left ventricular fibrosis by tranilast in rats with renovascular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890510007232

10.1080/07853890510007232

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16026115